Skip to main content
. 2018 Aug 30;18:858. doi: 10.1186/s12885-018-4759-x

Table 2.

% cancers of the vulva treated by surgery (and odds ratios for surgery) as part of the primary course of treatment; Australian major public hospitals, 1984–2016 diagnoses

Number of cases Surgery (%) p value*
Mann-Whitney or Fisher Exact Test
Odds ratiosa - adjusted (95% CIs)
All (n = 383) 93.7
Age at diagnosis (yrs.):
 < 50 (n = 56) 98.2 MW p = 0.452 1.00
 50–69 (n = 100) 91.0 0.28 (0.03, 2.58)
 70–79 (n = 113) 95.6 0.64 (0.06, 6.38)
 80+ (n = 114) 92.1 0.30 (0.03, 2.77)
FIGO stage:
 I (n = 167) 98.2 MW p = < 0.001 (excluding UK) 1.00
 II (n = 103) 97.1 0.70 (0.13, 3.87)
 III (n = 68) 83.8 0.13 (0.03, 0.53)
 IV (n = 29) 79.3 0.11 (0.02, 0.53)
 (Unknown (n = 16)) (93.8) (0.76 (0.07, 8.87))
Differentiation:
 Well (n = 102) 99.0 MW p = 0.002 (excluding UK) 1.00
 Moderate (n = 136) 94.1 0.25 (0.03, 2.28)
 Poorly/undifferentiated (n = 75) 90.7 0.22 (0.02, 0.53)
 (Unknown (n = 70) (88.6) (0.13 (0.01, 1.28))
Histology:
 Squamous cell carcinoma (n = 341) 94.4 FET p = 0.165 1.00
 Other (n = 42) 88.1 0.59 (0.16, 2.13)
Socioeconomic (SEIFA):
 Low (n = 138) 96.4 MW p = 0.021 1.00
 Low/med (n = 75) 94.7 0.58 (0.13, 2.64)
 Med/high (n = 77) 94.8 0.69 (0.15, 3.05)
 High (n = 93) 88.2 0.33 (0.10, 1.13)
Geographic remoteness:
 Low (n = 314) 93.6 MW p = 0.757 1.00
 Moderate (n = 45) 91.1 0.35 (0.09, 1.40)
 High (n = 24) 100.0 0.00 (0.00, 3.26)
Diagnostic period (calendar years.):
 1984–99 (n = 199) 95.5 FET p = 0.205 1.00
 2000–16 (n = 184) 91.8 0.79 (0.28, 2.20)

*Derived from Mann-Whitney U Test (ordinal) or Fisher Exact Test (binary)

aDerived from multiple logistic regression, adjusting for other variables in the Table